Live Breaking News & Updates on Lipocine inc

Stay informed with the latest breaking news from Lipocine inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Lipocine inc and stay connected to the pulse of your community

Lipocine (NASDAQ:LPCN) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research report released on Saturday morning. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance LPCN opened at $4.80 on Friday. Lipocine has a fifty-two week low of $2.31 and a fifty-two week high of $7.15. […]

Lipocine-inc , Free-report , Get-free-report , Lipocine-daily , Lipocine , Nasdaq-lpcn , Lpcn , Medical , Initiated-coverage , Stocknews-com ,

Short Interest in Lipocine Inc. (NASDAQ:LPCN) Increases By 155.6%

Lipocine Inc. (NASDAQ:LPCN – Get Free Report) was the recipient of a large increase in short interest during the month of April. As of April 15th, there was short interest totalling 278,400 shares, an increase of 155.6% from the March 31st total of 108,900 shares. Currently, 5.4% of the company’s shares are sold short. Based […]

Nasdaq , Lipocine-inc , Lipocine-company-profile , Get-free-report , Lipocine-daily ,

Lipocine (LPCN) Reports Positive LPCN 2401 Clinical Results

Lipocine (LPCN) Reports Positive LPCN 2401 Clinical Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , American , Mahesh-patel , Frank-greenway , Jaime-almandoz , Nasdaq , Energyx-ray-absorptiometry , Lipocine-inc , Weight-wellness-program , Pennington-biomedical-research-center , Ut-southwestern-medical-center , Dual-energyx-ray-absorptiometry

Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity

LPCN 2401 treatment resulted in statistically significant body composition improvement in menIncreased lean mass (LM) by 4.4% and decreased fat mass (FM) by 6.7%Reduced android fat (AF) by 4.1% and

United-states , American , Jaime-almandoz , Mahesh-patel , Frank-greenway , Pennington-biomedical-research-center , Nasdaq , Ut-southwestern-medical-center , Prnewswire-lipocine-inc , Energyx-ray-absorptiometry , Weight-wellness-program , Lipocine-inc

Lipocine (NASDAQ:LPCN) Receives New Coverage from Analysts at StockNews.com

Lipocine (NASDAQ:LPCN) Receives New Coverage from Analysts at StockNews.com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Renaissance-technologies , Lipocine-inc , Millennium-management , Lipocine-company-profile , Topco-ltd , Goldman-sachs-group-inc , Free-report , Get-free-report , Sachs-group , State-street-corp , Street-corp

Hepatology Month in Review: March 2024

Hepatology Month in Review: March 2024
hcplive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hcplive.com Daily Mail and Mail on Sunday newspapers.

Rajarshi-banerjee , Drug-administration , Lipocine-inc , Intercept-pharmaceutical-complete-response-letter , Juan-pablo-arab , Madrigal-pharmaceutical , Asian-pacific-association , Skeletal-muscle-index , New-drug-application ,

StockNews.com Begins Coverage on Lipocine (NASDAQ:LPCN)

StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a report published on Tuesday. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance Shares of LPCN stock opened at $5.20 on Tuesday. The stock’s 50 day simple moving average is $4.04 and its 200 day simple […]

Lipocine-inc , Millennium-management , Renaissance-technologies , Blackrock-inc , Lipocine-company-profile , Goldman-sachs-group-inc , Free-report , Get-free-report , Street-corp , Goldman-sachs-group , Sachs-group

Lipocine (NASDAQ:LPCN) Coverage Initiated by Analysts at StockNews.com

Lipocine (NASDAQ:LPCN) Coverage Initiated by Analysts at StockNews.com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Lipocine-company-profile , Renaissance-technologies , Millennium-management , Nasdaq , Lipocine-inc , Topco-ltd , Goldman-sachs-group-inc , Get-free-report , Sachs-group , State-street-corp , Street-corp

Lipocine (LPCN) Reports Positive Week 52 Results from LPCN 1148 Phase 2 Study

Lipocine (LPCN) Reports Positive Week 52 Results from LPCN 1148 Phase 2 Study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Jennifer-lai , Arunj-sanyal , Mahesh-patel , Lipocine-inc , Virginia-commonwealth-university , Nasdaq , Stravitz-sanyal-institute-for-liver-disease-metabolic-health , For-placebo , During-stage , Through-week , Placebo-converted

Lipocine Announces Positive Week 52 Results from LPCN 1148 Phase 2 Study in Patients with Cirrhosis

Met primary and Hepatic Encephalopathy endpoints in Phase 2 studyIncrease in Skeletal Muscle Index observed at Week 24 was maintained through 52 weeksParticipants on placebo increased SMI when...

United-states , Arunj-sanyal , Mahesh-patel , Jennifer-lai , Prnewswire-lipocine-inc , Stravitz-sanyal-institute-for-liver-disease-metabolic-health , Lipocine-inc , Nasdaq , Virginia-commonwealth-university , Skeletal-muscle-index , Overt-hepatic , For-placebo